Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.95
0.102.6%
Last update: Aug 24, 8:17 AM
Protara Therapeutics Inc (TARA) Stock Price, Quote, News & History
TARANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protara Therapeutics (TARA) stock?
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Who are Protara Therapeutics (TARA) competitors?
Other companies in Protara Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Protara Therapeutics (TARA) stock?
Protara Therapeutics has a consensus price target of $22.64.
What is the current price for Protara Therapeutics (TARA)?
The stock price for Protara Therapeutics (NASDAQ: TARA) is $3.95 last updated August 24, 2026 at 8:17 AM EDT.
Does Protara Therapeutics (TARA) pay a dividend?
There are no upcoming dividends for Protara Therapeutics.
When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?
Protara Therapeutics does not have any upcoming earnings scheduled.
Is Protara Therapeutics (TARA) going to split?
There is no upcoming split for Protara Therapeutics.
What sector and industry does Protara Therapeutics (TARA) operate in?
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
